⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20840050 | 1.00 | — | — | |
| SCHEMBL6660160 | 0.88 | LMNA (0.35) | — | |
| SCHEMBL1987972 | 0.88 | LMNA (0.32) | — | |
| SCHEMBL22531379 | 0.85 | — | — | |
| SCHEMBL2790728 | 0.85 | — | — | |
| SCHEMBL10703153 | 0.81 | ALDH1A1 (0.30) | — | |
| SCHEMBL892398 | 0.81 | CA2 (0.32) | — | |
| SCHEMBL15256805 | 0.80 | HSD17B10 (0.37) | — | |
| SCHEMBL11021303 | 0.80 | LMNA (0.37) | — | |
| SCHEMBL15384169 | 0.79 | HSD17B10 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263040-B2 | contrast agents for necrosis imaging, diagnosis of changes in the lymphatic system, inflammatory diseases, cardiovascular diseases, tumour imaging; radioactive materials use in radiotherapy | BAYER SCHERING PHARMA AG (DE) | 2012-09-11 | — | — | US | disclosed |
| EP-2089362-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG GROUP, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-08-19 | — | — | EP | disclosed |
| US-20080159954-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG RADICAL, PROCESSES FOR THEIR PREPARATION, AND THEIR USE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2008-07-03 | — | — | US | disclosed |
| WO-2008046463-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG GROUP, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-04-24 | — | — | WO | disclosed |
| EP-1450774-A4 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARM INC (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20050020559-A1 | Chlorin photosensitizing agents for use in photodynamic therapy | MIRAVANT PHARMACEUTICALS, INC., | 2005-01-27 | — | — | US | disclosed |
| EP-1450774-A2 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | Miravant Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003028629-A2 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARMACEUTICALS, INC. (US) | 2003-04-10 | — | — | WO | disclosed |